4.3 Article

Surgical Site Infections

Journal

SURGICAL CLINICS OF NORTH AMERICA
Volume 94, Issue 6, Pages 1245-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.suc.2014.08.008

Keywords

Surgical site infection; Surgical wound infections; Antibiotic prophylaxis; Infection control; Postoperative complication

Categories

Ask authors/readers for more resources

Surgical site infections are a major contributor to morbidity and mortality in postsurgical care. Risk for surgical site infection is multifactorial and includes a host of microbial, patient-related, and procedure-related factors. Prevention of surgical infection relies on optimization of patient factors and use of a variety of evidence-based pharmacologic and nonpharmacologic measures. At the forefront of these measures is antimicrobial prophylaxis, which has been shown to be effective at reducing risk of surgical site infection. As guidelines for prevention of surgical site infection become increasingly complex and nuanced, surgical infection outcomes are increasing tied to quality outcome and performances measures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Urine intestinal fatty acid-binding protein predicts acute mesenteric ischemia in patients

Saad Y. Salim, Pang Y. Young, Thomas A. Churchill, Rachel G. Khadaroo

JOURNAL OF SURGICAL RESEARCH (2017)

Meeting Abstract Surgery

Oncostatin M Primes Macrophages for an Enhanced Pro-Inflammatory Response

Rachel G. Khadaroo, Pang Y. Young, Qaasim N. Mian, Jeremy C. Young, Catherine A. Compston, Thomas F. Mueller

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)

Article Microbiology

VSL#3 probiotics provide protection against acute intestinal ischaemia/reperfusion injury

S. Y. Salim, P. Y. Young, C. M. Lukowski, K. L. Madsen, B. Sis, T. A. Churchill, R. G. Khadaroo

BENEFICIAL MICROBES (2013)

Meeting Abstract Medicine, General & Internal

Oncostatin M receptor is a sensitive and early marker of kidney injury

Barbara Pedrycz, Pang Young, Catherine Compston, Valerie Luyckx, Julie Ho, Valeria Mas, Lin-Fu Zhu, Donald Grynoch, Rachel Khadaroo, Thomas Mueller

SWISS MEDICAL WEEKLY (2014)

Article Surgery

A Descriptive Survey Study on the Effect of Age on Quality of Life Following Stoma Surgery

Selina K. Wong, Pang Y. Young, Sandy Widder, Rachel G. Khadaroo

OSTOMY WOUND MANAGEMENT (2013)

Article Surgery

Transplantation for Hepatocellular Carcinoma

Angela Hill, Franklin Olumba, William Chapman

Summary: Transplantation for HCC is a complex topic, requiring considerations of multiple factors. Balancing tumor size with post-transplant outcome is still an ongoing challenge. Tumor downstaging and the use of new technologies have increased the number of HCC transplants, and these advances can also be applied to other liver tumors.

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Liver Transplant for Intrahepatic Cholangiocarcinoma

Olanrewaju A. Eletta, Guergana G. Panayotova, Keri E. Lunsford

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Donation After Circulatory Death Liver Transplantation Early Challenges, Clinical Improvement, and Future Directions

Brianna Ruch, Kayla Kumm, Sandra Arias, Nitin N. Katariya, Amit K. Mathur

Summary: DCD liver transplantation is an underutilized method that can increase access to liver transplantation. With proper donor and recipient selection, matching, surgical technique, and perioperative management, these transplants can achieve similar patient and graft survival rates as DBD liver transplantation. The main limitations in the further growth of DCD liver transplantation are driven by risk aversion, and the current experience is mainly concentrated in large centers. With the advancement of regional and machine perfusion techniques, the definition of a viable DCD liver allograft may be redefined, encouraging wider usage and acceptance.

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation

Lauren Matevish, Madhukar S. Patel, Parsia A. Vagefi

Summary: Downstaging has been shown to be feasible within UNOS-DS criteria, with successful long-term outcomes. Interventional liver-directed therapies have been the standard, but systemic therapies are becoming more effective. Immunotherapy holds promise in downstaging, but further trials are needed to assess feasibility and safety. Individual expertise will continue to guide treatment until more data is available.

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Current Status of Liver Transplantation in North America

Hassan Aziz, Paramita Nayak, David C. Mulligan

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

How to Determine Unresectability in Hilar Cholangiocarcinoma

Catherine G. Pratt, Jenna N. Whitrock, Shimul A. Shah, Zhi Ven Fong

Summary: hCCA is a biologically aggressive disease and surgical resection is the only curative treatment. Factors such as patient's physical condition, tumor involvement, residual liver volume, and assessment of metastatic disease heavily influence the feasibility of surgical resection. A multidisciplinary, holistic, and individualized approach is critical for accurately determining resectability and optimizing clinical outcomes for patients with hCCA.

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Donor Viral Hepatitis and Liver Transplantation

Sara-Catherine Whitney Zingg, Kristina Lemon

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Liver Transplantation for Hilar Cholangiocarcinoma

Christopher J. Sonnenday

SURGICAL CLINICS OF NORTH AMERICA (2024)

Article Surgery

Role of Machine Perfusion in Liver Transplantation

Alban Longchamp, Tsukasa Nakamura, Korkut Uygun, James F. Markmann

SURGICAL CLINICS OF NORTH AMERICA (2024)